By Avon Protection reported a stronger performance in the second half of fiscal 2023 compared to the first half. This was attributed to an increase in its order book and higher underlying earnings. Overall, the company’s performance for the year was in line with expectations.
Shares of Avon Protection were up by 8.4%, or 56.0 pence, at 725.0 pence as of 1045 GMT.
Loungers
Loungers experienced strong revenue growth in the first half of the year, which was driven by an increase in like-for-like sales and the implementation of its progressive expansion strategy.
Shares of Loungers increased by 1.1%, or 2.0 pence, reaching 189.0 pence.
Allergy Therapeutics
Allergy Therapeutics announced that it will raise approximately £40.75 million ($49.6 million) through an open offer and subscription. This deal is part of a previous agreement with ZQ Capital Management Ltd. and Southern Fox Investments Ltd. Furthermore, this transaction has triggered a mandatory offer for the biotechnology company.
Shares of Allergy Therapeutics declined by 3.45%, or 0.05 pence, and were trading at 1.4 pence.
Christie Group
Although improved invoicing levels were observed for the second half of the year to date, Christie Group highlighted that there is still uncertainty regarding the exact timing of transactions. Some transactions may be delayed until 2024.
Shares of Christie Group dropped by 2.5%, or 2.5 pence, and were valued at 97.5 pence.
Chrysalis Investments
Chrysalis Investments plans to propose a capital allocation policy to its shareholders. The proposal includes a share buyback worth £100 million pounds and a revision to its performance-fee arrangement.
Shares of Chrysalis Investments rose by 8.3%, or 4.6 pence, and were trading at 59.8 pence.
Market Updates
FTSE Small-Cap: -0.54%
AIM: -0.36%
Comments